Skip to main content

Advertisement

Major complications following exenteration in cases of pelvic malignancy: an 18-year experience

Article metrics

  • 1484 Accesses

Background

Despite radical surgery, up to 33% of patients with rectal cancer will develop locoregional relapse. The management of these patients is particularly challenging. Surgery is the mainstay of treatment for those with a mobile recurrence. However, the majority of patients develop recurrence involving the pelvic wall. In these patients, multimodality therapy including radical surgery and intraoperative radiotherapy have been reported with 5-year survival of up to 31% and local control rates of 50–71%. The most important factor for obtaining long-term local control and survival is R0 resection. Extended surgery such as abdomino-sacral resection has not been popular because of 5-year survival rates of 16–31%, and significant postoperative morbidity. Re-recurrence following surgery occurs locally and in the lung, and remains a significant problem. In surgical treatment for local recurrence, surgeon-related factors are crucial. A staging system using degree of fixation and other prognostic factors should be developed so that appropriate treatment modalities are applied to each case. Despite radical surgery, up to 33% of patients with rectal cancer will develop locoregional relapse. The management of these patients is particularly challenging. Surgery is the mainstay of treatment for those with a mobile recurrence. However, the majority of patients develop recurrence involving the pelvic wall. In these patients, multimodality therapy including radical surgery and intraoperative radiotherapy have been reported with 5-year survival of up to 31% and local control rates of 50–71%. The most important factor for obtaining long-term local control and survival is R0 resection. Objective: To analyze the major complications after exenteration of colo-rectal and canal anal malignancies.

Materials and methods

Fifty nine patients with colo-rectal and canal anal malignancies underwent pelvic exenteration (PE) between 1984 and 2002. 48 patients underwent posterior pelvic exenteration PPE, 8 total pelvic exenteration and 3 posterior supraelevadora exenteration were performed.

Results

Major complications in the operative field involving the urinary tract infection or the wound dehiscence occurred in 29 patients (49.15%). The mortality rate was 3.3%. Major complications often occurred in advanced primary colorectal cancer affecting those with recurrent malignancies.

Conclusion

PE is more beneficial to patients with colorectal and canal anal cancer recurrence than to those with recurrent cancer. Knowledge of the inherent complications and morbidity of PE is essential.

Author information

Correspondence to Horacio Lopez-Basave.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Lopez-Basave, H., Morales-Vasquez, F., Ochoa, E. et al. Major complications following exenteration in cases of pelvic malignancy: an 18-year experience. BMC Cancer 7, A37 (2007) doi:10.1186/1471-2407-7-S1-A37

Download citation

Keywords

  • Rectal Cancer
  • Radical Surgery
  • Local Control Rate
  • Multimodality Therapy
  • Pelvic Exenteration